New data supports GraftAssure commercialization effortsMulti-center study featured 249 biopsy-matched patientsProprietary ...
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
Three-site reproducibility study completed by Tampa General Hospital, Mayo Clinic, and Baylor Scott & White HealthSufficient clinical samples collected to support statistical analysis and FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results